Economic burden of secondary progressive multiple sclerosis: DISCOVER study

Economic burden of secondary progressive multiple sclerosis: DISCOVER study

Abstract Background To estimate the socioeconomic burden of people with secondary progressive multiple sclerosis (pwSPMS), considering direct health care, direct non-health care, and indirect costs, and to evaluate the relationship between costs and patients’ functional outcomes. Methods Observation...

Full description

Saved in:
Bibliographic Details
Main Authors: Celia Oreja-Guevara, José E. Meca-Lallana, Irene Gómez-Estévez, José-Ramón Ara, Miguel Ángel Hernández Pérez, Julia Gracia Gil, Ana María Alonso Torres, Belén Pilo de la Fuente, Lluís Ramió-Torrentà, Sara Eichau Madueño, Francisco Gascón-Giménez, Bonaventura Casanova, Sergio Martínez-Yélamos, Marta Aguado Valcárcel, Maria Luisa Martínez Ginés, Yasmina El Berdei Montero, Ana María López Real, Vicente González-Quintanilla, Carlos Lopez de Silanes, José Enrique Martínez-Rodríguez, Lucienne Costa-Frossard, Moisés Garcés Redondo, Andrés Labiano Fontcuberta, Fernando Castellanos-Pinedo, Juan Antonio García Merino, Carmen Muñoz Fernández, Tamara Castillo-Triviño, Virginia Meca-Lallana, Joaquín Peña Martínez, Alfredo Rodríguez-Antigüedad, José María Prieto González, Eduardo Agüera Morales, Inmaculada Pérez Molina, Dulce M. Solar Sánchez, Nicolás Herrera Varo, Marta Aguirre Vázquez, José Manuel Rodríguez Barrios, Jordi Río
Format: Article
Language:English
Published: BMC 2025-04-01
Series:BMC Health Services Research
Subjects:
Secondary progressive multiple sclerosis
Disability
Patient-reported outcomes
Socioeconomic burden
Indirect costs
Direct costs
Online Access:https://doi.org/10.1186/s12913-025-12592-1
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Background To estimate the socioeconomic burden of people with secondary progressive multiple sclerosis (pwSPMS), considering direct health care, direct non-health care, and indirect costs, and to evaluate the relationship between costs and patients’ functional outcomes. Methods Observational, cross-sectional, multicenter study with retrospective real-life clinical practice data collection from pwSPMS visiting the neurology services of 34 hospitals during 2019–2020. Clinical data included Expanded Disability Status Scale scores, number of relapses, magnetic resonance imaging, disease-modifying treatment (DMT), symptoms, and comorbidities from 24 months before the study visit. Resource use and allied costs were collected 12 months before the study visit. Patient-reported outcomes, functional and cognitive scales were also collected. Results 70% of pwSPMS used primary care services, and nearly 50% needed assistance in a daycare or rehabilitation center. Almost 60% of the participants were receiving DMT at the study visit, and 80% needed support for domestic/housekeeping tasks. More than 90% were inactive at work, with nearly 80% taking early retirement. The estimated total annual cost per pwSPMS in Spain was almost €41,500, of which more than 50% (€21,400) were indirect costs, followed by direct health care costs (30%, €11,300), and, finally, direct non-health care costs (about 20%, €8,800). Older patients with severe disabilities and worse functional outcomes incurred higher costs. Conclusions SPMS is a major burden on health care systems, patients, and society as a whole. Health care and societal policies should be aimed at improving the SPMS care pathway and minimizing patients’ funding of direct non-health care costs. Trial registration The trial is a non-interventional study. The NCC code is CBAF312AES01/NOV-EMS-2019–01.
ISSN:1472-6963

Similar Items